These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38310381)

  • 1. [An analysis of breast cancer patients with ultrasound BI-RADS 3 lesions after minimally invasive excision in clinicopathological features and influencing factors of residual tumor].
    Li L; Feng ZQ; Zhang LF; Wang RQ; Zhang XX; Liu LY; Yu LX; Yu ZG; Gao ZC
    Zhonghua Wai Ke Za Zhi; 2024 Feb; 62(2):135-140. PubMed ID: 38310381
    [No Abstract]   [Full Text] [Related]  

  • 2. A model combining BI-RADS® descriptors from pre-treatment B-mode breast ultrasound with clinicopathological tumor features shows promise in the prediction of residual disease after neoadjuvant chemotherapy.
    Kapetas P; Aggarwal R; Altuwayjiri B; Pinker K; Clauser P; Helbich TH; Baltzer PAT
    Eur J Radiol; 2024 Sep; 178():111649. PubMed ID: 39094464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
    Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
    J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.
    Ha SM; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    Br J Radiol; 2018 Jul; 91(1087):20170787. PubMed ID: 29658793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonographic Features of Primary Breast Lymphoma: An Analysis of 10 Cases.
    Liu X; Liu J; Chen S
    Curr Med Imaging; 2023; 19(6):579-586. PubMed ID: 35975864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of BI-RADS classification in Taiwanese breast cancer patients: BI-RADS 5 versus BI-RADS 0-4.
    Kuo YL; Cheng L; Chang TW
    Eur J Radiol; 2012 Jul; 81(7):1504-7. PubMed ID: 21477958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Short-term Follow-up with Ultrasound be Offered as an Acceptable Alternative to Immediate Biopsy or Surgery for Patients with First Ultrasound Diagnosis of BI-RADS 4A Lesions?
    He P; Chen W; Cui LG; Zhang H
    World J Surg; 2023 Sep; 47(9):2161-2168. PubMed ID: 37115232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of ultrasound classification in BI-RADS category 4 of breast complex cystic masses].
    Yao JP; Niu LJ; Wang Y; Geng CY; Chang Q; Chen Y; Zhu L
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):672-675. PubMed ID: 30293391
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic performance of ultrasound strain elastography for differentiation of malignant breast lesions.
    Georgieva M; Prantl L; Utpatel K; Wiesinger I; Stroszczynski C; Jung F; Jung EM
    Clin Hemorheol Microcirc; 2019; 71(2):237-247. PubMed ID: 30584133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of ultrasound, cytological, and histological features of 110 benign BI-RADS categories 4C and 5 nonpalpable breast lesions. The Institut Curie's experience.
    Farras Roca JA; Tardivon A; Thibault F; Rouzier R; Klijanienko J
    Cancer Cytopathol; 2021 Jun; 129(6):479-488. PubMed ID: 33689204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An audit of the results of ultrasound-guided core needle biopsy of mammography versus ultrasound screen-detected breast lesions.
    Rhee SJ; Han BK; Ko ES; Choi JS; Ko EY
    J Clin Ultrasound; 2017 Jun; 45(5):261-266. PubMed ID: 28182285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of contrast-enhanced ultrasound in the diagnosis of BI-RADS-US 4a lesions less than 2 cm in diameter.
    Yu MQ; Zhang LL; Jiang LP; Zhou AY
    Clin Hemorheol Microcirc; 2023; 83(3):195-205. PubMed ID: 35599475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic importance of ultrasound BI-RADS classification in breast cancer patients.
    Kim JY; Jung EJ; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC; Ha WS; Choi SK
    Jpn J Clin Oncol; 2015 May; 45(5):411-5. PubMed ID: 25670765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
    Yao MM; Joe BN; Sickles EA; Lee CS
    Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally Invasive Excision of Breast Masses under Ultrasound Guidance: A Single Center's Five-Year Experience on the Breast Lesion Excision System.
    Karakas HM; Yildirim G
    Breast J; 2022; 2022():1888726. PubMed ID: 35711894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Ultrasound-guided 8-Gauge Vacuum-assisted Excision System for the Removal of US-detectable Breast Lesions.
    Perretta T; Lamacchia F; Ferrari D; Beninati E; DI Tosto F; DE Stasio V; Meucci R; DI Stefano C; Buonomo OC; Vanni G; Pistolese CA
    Anticancer Res; 2020 Mar; 40(3):1719-1729. PubMed ID: 32132080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Strain Elastography on BI-RADS classification in small invasive lobular carcinoma.
    Chiorean AR; Szep MB; Feier DS; Duma M; Chiorean MA; Strilciuc Ș
    Med Ultrason; 2018 May; 20(2):148-153. PubMed ID: 29730679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
    Candelaria RP; Spak DA; Rauch GM; Huo L; Bassett RL; Santiago L; Scoggins ME; Guirguis MS; Patel MM; Whitman GJ; Moulder SL; Thompson AM; Ravenberg EE; White JB; Abuhadra NK; Valero V; Litton J; Adrada BE; Yang WT
    Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S35-S41. PubMed ID: 34272161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-guided wire localization biopsy in non-palpable breast lesions: predictive factors for malignancy.
    Yilmaz S; Ünal GK; Aslan HS; Değirmencioğlu S; Aykota MR
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1320-1327. PubMed ID: 35253188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Return to Routine Screening for BI-RADS 3 Lesions Detected at Supplemental Automated Whole-Breast Ultrasound in Women With Dense Breasts: A Prospective Study.
    Barr RG; DeSivestri A; Golatta M
    AJR Am J Roentgenol; 2021 Dec; 217(6):1313-1321. PubMed ID: 34259039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.